Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model. 2019

Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.

Transplantation of cardiomyocytes derived from induced pluripotent stem cell (iPSC-CMs) is a promising approach for increasing functional CMs during end-stage heart failure. Although major histocompatibility complex (MHC) class I matching between donor cells and recipient could reduce acquired immune rejection, innate immune responses may have negative effects on transplanted iPSC-CMs. Here, we demonstrated that natural killer cells (NKCs) infiltrated in iPSC-CM transplants even in a syngeneic mouse model. The depletion of NKCs using an anti-NKC antibody rescued transplanted iPSC-CMs, suggesting that iPSC-CMs activated NKC-mediated innate immunity. Surprisingly, iPSC-CMs lost inhibitory MHCs but not activating ligands for NKCs. Re-expression of MHC class I induced by IFN-γ as well as suppression of activating ligands by an antibody rescued the transplanted iPSC-CMs. Thus, NKCs impede the engraftment of transplanted iPSC-CMs because of lost MHC class I, and our results provide a basis for an approach to improve iPSC-CM engraftment.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D057026 Induced Pluripotent Stem Cells Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS. Human Induced Pluripotent Stem Cell,IPS Cell,IPS Cells,Induced Pluripotent Stem Cell,Fibroblast-Derived IPS Cells,Fibroblast-Derived Induced Pluripotent Stem Cells,Human Induced Pluripotent Stem Cells,hiPSC,Cell, Fibroblast-Derived IPS,Cell, IPS,Cells, Fibroblast-Derived IPS,Cells, IPS,Fibroblast Derived IPS Cells,Fibroblast Derived Induced Pluripotent Stem Cells,Fibroblast-Derived IPS Cell,IPS Cell, Fibroblast-Derived,IPS Cells, Fibroblast-Derived

Related Publications

Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
February 2009, Circulation research,
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
January 2019, Frontiers in immunology,
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
January 2012, PloS one,
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
July 2012, Journal of molecular and cellular cardiology,
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
December 2011, International journal of cardiology,
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
January 2011, Journal of pharmacological sciences,
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
January 2021, International journal of molecular sciences,
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
December 2017, Stem cell reports,
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
January 2021, Methods in molecular biology (Clifton, N.J.),
Yuki Nakamura, and Shigeru Miyagawa, and Shohei Yoshida, and Shigemi Sasawatari, and Toshihiko Toyofuku, and Koichi Toda, and Yoshiki Sawa
March 2016, Stem cell research,
Copied contents to your clipboard!